ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
3,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
3,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
4,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
5,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
9,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
12,1,Supraventricular extrasystoles,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
13,1,Cerebrospinal fluid reservoir placement,Cerebrospinal fluid therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
13,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
13,3,Meningitis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
13,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
13,5,Ventricular drainage,Cerebrospinal fluid therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
14,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
14,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
16,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,3,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
17,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
17,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
19,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
19,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
19,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
19,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
20,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
20,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
20,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
20,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
20,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
21,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,1,Antimicrobial susceptibility test resistant,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
22,2,Aortic valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
22,3,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
22,4,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
22,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,6,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
22,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
23,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
23,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
24,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
24,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
25,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
25,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
25,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
26,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
27,1,Abscess bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
27,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
27,3,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
27,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
27,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,6,Left ventricular dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
27,7,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
27,8,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
27,9,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
27,10,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
28,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
29,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
29,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
29,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,5,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,6,Mitral valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
29,7,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
29,8,Septic embolus,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
29,9,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
29,10,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
30,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
31,1,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
32,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
32,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
32,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,False positive investigation result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
33,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
33,4,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
34,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
34,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
34,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
35,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
36,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
36,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
36,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
36,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
36,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
37,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
37,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
38,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
38,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
39,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
40,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
42,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
43,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
43,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
43,4,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
44,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
44,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
44,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
45,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
45,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,4,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
46,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
47,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
48,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
48,2,Minimum inhibitory concentration,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
48,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
49,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
50,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
51,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
52,1,Minimum inhibitory concentration,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
52,2,Prosthetic valve endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
52,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
53,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
54,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
55,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
56,1,Antimicrobial susceptibility test resistant,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
56,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
56,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
57,2,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
57,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
57,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
58,1,Prosthetic valve endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
59,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
60,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
61,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
62,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
62,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
63,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
63,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
63,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
64,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
64,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
64,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
65,2,Myopathy,Myopathies,Muscle disorders,Musc,N
65,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
65,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
66,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
67,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
68,1,Aortic valve stenosis,Aortic valvular disorders,Cardiac valve disorders,Card,N
68,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
68,3,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
68,4,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
68,5,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
68,6,Minimum inhibitory concentration,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
68,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
68,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
68,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
69,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
69,2,Endocarditis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
70,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
71,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,3,Aortic valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
71,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
71,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,6,Continuous haemodiafiltration,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
71,7,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
72,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
72,2,Endocarditis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
73,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
73,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
74,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
74,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
75,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
75,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
76,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,2,Minimum inhibitory concentration,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
77,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
78,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
78,2,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
78,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
79,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
80,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
81,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,Y
81,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
82,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
83,1,Cardiac pacemaker removal,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
83,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
84,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
84,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
85,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
85,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
86,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
86,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
87,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
88,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
89,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
89,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
90,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
90,2,Cardiac infection,Cardiac infections,Infections - pathogen unspecified,Infec,N
90,3,Cardiac valve abscess,Cardiac infections,Infections - pathogen unspecified,Infec,Y
90,4,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
90,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
90,6,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,7,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
90,8,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
90,9,Klebsiella test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
90,10,Minimum inhibitory concentration,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
90,11,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
90,12,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
93,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
94,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
94,2,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
95,1,Acute lung injury,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
95,2,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
95,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
96,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
96,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
97,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
98,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
99,1,Cardiac valve abscess,Cardiac infections,Infections - pathogen unspecified,Infec,N
99,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,3,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
99,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
99,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
99,6,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
99,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
100,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
100,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
101,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
101,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
102,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
102,2,Cardiac valve abscess,Cardiac infections,Infections - pathogen unspecified,Infec,N
102,3,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
102,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
102,5,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,6,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
102,7,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
103,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
103,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
104,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
105,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
105,2,Peripheral nerve lesion,Mononeuropathies,Peripheral neuropathies,Nerv,N
106,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
106,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
106,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
107,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
107,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
107,3,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
107,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,5,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
107,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
107,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
107,8,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
109,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
110,1,Circumoral oedema,Angioedemas,Angioedema and urticaria,Skin,N
110,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
110,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
110,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
110,6,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
110,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,Y
112,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
112,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,3,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
113,1,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
113,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
113,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
114,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
114,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
115,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
116,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
116,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
117,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
118,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,2,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,Y
118,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
118,4,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
118,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
119,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
119,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
120,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
120,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
121,1,Bacterial test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
121,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
122,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
122,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
123,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
124,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
124,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
124,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
124,4,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
124,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
124,6,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
124,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
124,8,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
124,9,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
125,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
126,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
127,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
127,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
128,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
128,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
128,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
129,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
129,2,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
129,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
129,4,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
129,5,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
129,6,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
129,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
129,8,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
129,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
130,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
130,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
131,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
132,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
133,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
133,2,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
134,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
134,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
134,3,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
134,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
134,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
136,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
136,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
136,3,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
137,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
138,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
139,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,Y
140,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
140,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
141,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
142,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
142,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
142,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
142,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
142,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
143,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
144,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
144,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
144,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
145,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
145,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
146,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
146,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
147,1,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
148,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
149,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
150,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
150,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
151,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
152,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
152,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
153,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,Y
153,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
154,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
155,1,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
156,1,Antimicrobial susceptibility test resistant,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
157,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
158,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
158,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
158,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
158,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
158,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
158,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
158,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
159,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
159,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
160,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
161,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
161,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
162,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
163,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
164,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
165,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
165,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
166,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
166,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
167,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
168,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
168,2,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
168,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
168,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
168,5,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
168,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
168,7,Splenic embolism,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
168,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
169,1,Seizure like phenomena,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
170,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
171,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
171,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
171,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
172,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
173,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
173,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
174,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
175,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
176,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
176,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
177,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
177,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
178,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
178,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
178,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
179,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
180,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
180,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
181,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
181,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
182,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
183,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
184,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
184,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
184,3,Headache,Headaches NEC,Headaches,Nerv,N
184,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
184,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
184,6,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
185,1,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
185,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
185,3,Endocarditis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
185,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
185,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
187,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
188,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
188,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
188,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
188,4,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
188,5,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
188,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
188,7,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
189,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
189,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
190,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
191,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
191,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
191,3,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
191,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
191,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
192,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
192,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
193,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
194,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
195,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
195,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
195,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
195,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
196,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
197,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
197,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
198,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
198,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
198,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
199,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
200,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
201,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
202,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
203,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
204,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
205,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
206,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
206,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
207,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
207,2,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
208,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
209,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
210,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
210,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
210,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
210,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
210,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
211,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
212,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
212,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
212,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
212,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
212,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
212,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
213,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
214,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
215,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
216,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
217,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
218,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
219,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
220,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
220,2,Diabetic foot infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
220,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
220,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
221,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
221,2,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
221,3,Pulmonary eosinophilia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
221,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
221,5,Weaning failure,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
222,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
222,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
222,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
223,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
224,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
224,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
224,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
224,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
224,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
225,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
226,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
227,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
227,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
227,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
227,4,Pulmonary eosinophilia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
228,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
228,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
228,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
228,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
229,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
229,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
230,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
230,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
231,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
232,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
233,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
233,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
234,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
234,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
234,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
234,4,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
234,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
234,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
234,7,Pulmonary eosinophilia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
234,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
234,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
235,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
236,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
237,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
238,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
239,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
240,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
240,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
240,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
241,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
242,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
242,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
242,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
242,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
242,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
243,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
243,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
244,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
245,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
245,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
245,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
246,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
246,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
247,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
247,2,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
248,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
249,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
249,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
249,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
250,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,Y
250,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
251,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
251,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
251,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
252,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
253,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
254,1,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
254,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
254,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
254,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
254,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
255,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
255,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
256,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
256,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
257,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
258,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
259,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
259,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
260,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
261,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
261,2,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
261,3,Device dislocation,Device issues NEC,Device issues,Prod,N
261,4,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
261,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
262,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
263,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
264,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
265,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
266,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
266,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
267,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
268,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
268,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
269,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
270,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
270,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
271,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
271,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
271,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
271,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
271,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
271,6,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
272,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
273,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
274,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
274,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
274,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
275,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
275,2,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
275,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
276,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
276,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
276,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
276,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
276,5,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
277,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
277,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
277,3,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
277,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
278,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
278,2,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
279,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
280,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
281,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
282,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
282,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
282,3,Carbon dioxide increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
282,4,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
282,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
282,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
282,7,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
282,8,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
282,9,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
282,10,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
282,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
282,12,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
282,13,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
282,14,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
283,1,Breath sounds abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
283,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
283,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
283,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
283,5,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
283,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
283,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
284,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
285,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
285,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
285,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
285,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
286,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
286,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
286,3,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
286,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
286,5,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
286,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
286,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
287,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
287,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
288,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
288,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
289,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
290,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
291,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
292,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
292,2,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
293,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
294,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
295,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
295,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
295,3,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
296,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
296,2,Blood creatine phosphokinase abnormal,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
296,3,Glomerular filtration rate abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
296,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
296,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
297,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
298,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
299,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
300,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
301,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
302,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
302,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
302,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
303,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
303,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
303,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
303,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
303,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
303,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
303,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
303,8,Product used for unknown indication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
303,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
304,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
305,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
305,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
306,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
307,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
308,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
308,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
308,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
308,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
308,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
309,1,Deafness,Hearing losses,Hearing disorders,Ear,N
309,2,Glomerular filtration rate abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
310,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
311,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
311,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
311,3,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
311,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
311,5,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
311,6,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
311,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
312,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
312,2,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
312,3,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
312,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
313,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
313,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
313,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
313,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
313,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
314,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
315,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
316,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
316,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
316,3,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
316,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
316,5,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
316,6,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
316,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
316,8,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
316,9,Pulmonary eosinophilia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
317,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
317,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
317,3,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
317,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
317,5,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
317,6,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
317,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
317,8,Pulmonary eosinophilia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
318,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
318,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
318,3,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
318,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
318,5,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
318,6,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
318,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
318,8,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
318,9,Pulmonary eosinophilia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
319,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
320,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
320,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
321,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
322,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
322,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
323,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
323,2,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
324,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
325,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
325,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
326,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
326,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
327,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
328,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
328,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
329,1,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
330,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
331,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
332,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
333,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
334,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
335,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
336,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
336,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
337,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
338,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
338,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
338,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
338,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
338,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
338,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
338,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
338,8,Product used for unknown indication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
338,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
339,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
340,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
340,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
340,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
340,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
340,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
341,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
341,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
341,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
341,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
341,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
341,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
341,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
341,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
342,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
342,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
342,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
342,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
343,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
343,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
343,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
343,4,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
343,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
343,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
343,7,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
344,1,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
344,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
344,3,Endocarditis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
344,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
344,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
346,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
346,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
346,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
346,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
346,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
346,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
346,7,Product used for unknown indication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
346,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
347,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
347,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
347,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
347,4,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
347,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
348,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
348,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
349,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
350,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
351,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
351,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
351,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
352,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
353,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
353,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
353,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
353,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
353,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
353,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
354,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
355,1,Confusion postoperative,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
356,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
356,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
356,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
356,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
356,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
356,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
356,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
357,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
357,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
357,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
358,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
358,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
359,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
359,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
359,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
359,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
359,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
359,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
359,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
359,8,Product used for unknown indication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
359,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
360,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
361,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
361,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
362,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
363,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
364,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
365,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
365,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
365,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
365,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
365,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
365,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
365,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
365,8,Product used for unknown indication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
365,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
366,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
367,1,Antimicrobial susceptibility test resistant,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
367,2,Drug dispensed to wrong patient,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
367,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
367,4,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
367,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
367,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
367,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
367,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
367,9,Minimum inhibitory concentration,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
367,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
367,11,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
367,12,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
367,13,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
367,14,Therapeutic response delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
367,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
367,16,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
367,17,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
367,18,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
368,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
368,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
369,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
370,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
371,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
371,2,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
372,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
373,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
374,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
375,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
376,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
376,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
376,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
376,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
376,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
377,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
377,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
377,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
377,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
377,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
377,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
378,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
379,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
380,1,Haematological infection,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
380,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
381,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
381,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
382,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
383,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
384,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
385,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
386,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
387,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
388,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
389,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
390,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
390,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
390,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
391,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
392,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
393,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
393,2,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
393,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
393,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
393,5,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
393,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
394,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
394,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
394,3,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
394,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
394,5,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
394,6,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
394,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
395,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
396,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
396,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
396,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
397,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
398,1,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
399,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
400,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
401,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
401,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
401,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
401,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
401,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
401,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
401,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
401,8,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
402,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
403,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
404,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
405,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
406,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
407,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
408,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
409,1,Blood creatine phosphokinase,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
410,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
